Data / Drug companies / Ester Local Anesthetic
Ester Local Anesthetic drugs: 13 drugs from 25 companies in the FDA NDC directory
Ester Local Anesthetic is an FDA established pharmacologic class. The FDA National Drug Code Directory lists 39 products in this class from 25 companies, covering 13 drugs by generic name. The main marketing category is new drug applications (NDA), and the newest product started marketing on March 6, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- 25Companies
- 39Products
- 13Drugs by generic name
Drugs in the Ester Local Anesthetic class
Ranked by number of companies that list the drug.
| Drug | Products here | Companies listing it |
|---|---|---|
| Lidocaine | 1 | 216 |
| Tetracaine hydrochloride | 11 | 9 |
| Tetracaine | 4 | 4 |
| Chloroprocaine hydrochloride | 7 | 3 |
| Tetracaine hcl | 2 | 2 |
| Benzocaine, butamben, and tetracaine hydrochloride | 6 | 1 |
| Chloroprocaine hci | 2 | 1 |
| (chloroprocaine hci | 1 | 1 |
| Benzocaine, lidocaine, tetracaine | 1 | 1 |
| Chloroprocaine hydrochloride ophthalmic gel | 1 | 1 |
| Lidocaine and tetracaine | 1 | 1 |
| Lidocaine, tetracaine | 1 | 1 |
| Tetracaine, mineral | 1 | 1 |
Companies with the most products in this class
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Cetylite Industries, Inc. | 6 | solution; gel | Other unapproved drugs | January 1, 1960 |
| Fresenius Kabi USA, LLC | 4 | injection, solution | New drug applications (NDA) | October 14, 2010 |
| HF Acquisition Co LLC, DBA HealthFirst | 3 | injection, solution | New drug applications (NDA) | October 29, 2019 |
| Hikma Pharmaceuticals USA Inc. | 2 | injection, solution | Generic drugs (ANDA) | November 1, 1998 |
| Sambria Pharmaceuticals, LLC | 2 | cream | Over the counter monograph drugs | September 26, 2023 |
| Somerset Therapeutics, LLC | 2 | solution | Generic drugs (ANDA) | December 23, 2024 |
| Sportpharm LLC | 2 | solution | Generic drugs (ANDA) | December 23, 2024 |
| A-S Medication Solutions | 1 | solution | New drug applications (NDA) | November 2, 2016 |
| Alcon Laboratories, Inc. | 1 | solution | New drug applications (NDA) | November 2, 2016 |
| Bausch & Lomb Americas Inc. | 1 | solution/ drops | Authorized generics (NDA) | September 21, 2022 |
| Bausch & Lomb Incorporated | 1 | solution/ drops | New drug applications (NDA) | September 23, 2022 |
| Bausch Health US LLC | 1 | solution/ drops | New drug applications (NDA) | June 27, 2019 |
| Bellus Medical, LLC | 1 | gel | Over the counter monograph drugs | June 1, 2017 |
| Bpi Labs LLC | 1 | injection | Other unapproved drugs | June 26, 2020 |
| Centura Pharmaceuticals Inc | 1 | ointment | Over the counter monograph drugs | October 30, 2016 |
| Guangdong Aimu Biological Technology Co., Ltd | 1 | cream | Over the counter monograph drugs | June 24, 2024 |
| Harrow Eye, LLC | 1 | gel | New drug applications (NDA) | September 27, 2022 |
| Ipg Pharmaceuticals, Inc. | 1 | cream | New drug applications (NDA) | March 6, 2026 |
| M2B Pharma LLC | 1 | cream | Over the counter monograph drugs | February 4, 2020 |
| Oceanside Pharmaceuticals | 1 | solution/ drops | New drug applications (NDA) | June 27, 2019 |
| Pagari Life Science Corp. | 1 | ointment | Over the counter monograph drugs | May 1, 2024 |
| ProPharma Distribution | 1 | injection, solution | Generic drugs (ANDA) | November 1, 1998 |
| Remedyrepack Inc. | 1 | solution | New drug applications (NDA) | September 24, 2024 |
| SofTap Inc | 1 | cream | Other unapproved drugs | May 6, 2022 |
| Unit Dose, Ltd. | 1 | cream | Over the counter monograph drugs | January 20, 2016 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, solution | 10 | 25.6% |
| Solution | 10 | 25.6% |
| Cream | 7 | 17.9% |
| Gel | 4 | 10.3% |
| Solution/ drops | 4 | 10.3% |
| Ointment | 2 | 5.1% |
| Injection | 1 | 2.6% |
| Aerosol, spray | 1 | 2.6% |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.